Dobutamine stress MR

  • Eike Nagel


In recent years, magnetic resonance (MR) imaging has become the accepted reference standard for the assessment of global left ventricular volumes and mass, as MR methods are both accurate and highly reproducible [6]. With the advance of high-resolution breath hold techniques for the visualization of myocardial motion, this application has gained widespread acceptance for the assessment of left ventricular function and regional wall motion. At rest, these techniques can be used to detect, localize, and quantitate myocardial infarction. Low dose dobutamine stress can be used to detect hibernating myocardium and high dose dobutamine stress can be used to identify ischemic myocardium. This chapter will deal with low and high dose dobutamine stress. An alternative technique (delayed enhancement) to assess myocardial infarction and hibernating myocardium is found in Chapter 20.


Cardiovascular Magnetic Resonance Wall Motion Abnormality Left Ventricular Segment Baseline Systolic Blood Pressure Breath Hold Technique 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bach DS, et al (1994) False positive dobutamine stress echocardiograms: characterization of clinical, echocardiographic and angiographic findings. J Am Coll Cardiol 24(4):928–933PubMedCrossRefGoogle Scholar
  2. 2.
    Baer FM, et al (1994) Gradient-echo magnetic resonance imaging during incremental dobutamine infusion for the localization of coronary artery stenoses. Eur Heart J 15(2):218–225PubMedGoogle Scholar
  3. 3.
    Baer FM, et al (1995) Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability. Circulation 91(4):1006–1015PubMedCrossRefGoogle Scholar
  4. 4.
    Baer FM, et al (1996) Comparison of dobutamine transesophageal echocardiography and dobutamine magnetic resonance imaging for detection of residual myocardial viability. Am J Cardiol 78(4):415–419PubMedCrossRefGoogle Scholar
  5. 5.
    Baer FM, et al (1998) Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol, 31(5):1040–1048PubMedCrossRefGoogle Scholar
  6. 6.
    Bogaert JG, et al (1995) Left ventricular quantification with breath-hold MR imaging: comparison with echocardiography. MAGMA 3(1):5–12PubMedCrossRefGoogle Scholar
  7. 7.
    Bremerich J, et al (1997) Noninvasive stress testing of myocardial ischemia: comparison of MRI perfusion and wall motion analysis to 99mTcMIMI SPECT, relation to coronary angiography. Eur Radiol 7:990–995PubMedCrossRefGoogle Scholar
  8. 8.
    Cerqueira MD, et al (2002) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105(4):539–542PubMedCrossRefGoogle Scholar
  9. 9.
    Fischer S, Wickline S, Lorenz C (1999) Novel real-time R-wave detection algorithm based on the vectorcardiogram for accurate gated magnetic resonance acquisitions. Magn Reson Med 42:361–370PubMedCrossRefGoogle Scholar
  10. 10.
    Geleijnse ML, Fioretti PM, Roelandt JR (1997) Methodology, feasibility, safety and diagnostic accuracy of dobutamine stress echocardiography. J Am Coll Cardiol 30(3):595–606PubMedCrossRefGoogle Scholar
  11. 11.
    Heyndrickx C, et al (1978) Depression of regional blood flow and wall thickening after brief coronary occlusion. Am J Physiol 234:H653–660Google Scholar
  12. 12.
    Hoffmann R, et al (1996) Analysis of interinstitutional observer agreement in interpretation of dobutamine stress echocardiograms. J Am Coll Cardiol 27(2):330–336PubMedCrossRefGoogle Scholar
  13. 13.
    Hundley WG, et al (1999) Utility of fast cine magnetic resonance imaging and display for the detection of myocardial ischemia in patients not well suited for second harmonic stress echocardiography. Circulation 100:1697–1702PubMedCrossRefGoogle Scholar
  14. 14.
    Kraitchman DL, et al (1996) Myocardial perfusion and function in dogs with moderate coronary stenosis. Magn Reson Med 35:771–780PubMedCrossRefGoogle Scholar
  15. 15.
    Lorenz CH, et al (1998) Interactive cardiac scan planning on a standard clinical MR scanner. In: Proceedings of the ISMRM. SydneyGoogle Scholar
  16. 16.
    Mertes H, et al (1993) Symptoms, adverse effects, and complications associated with dobutamine stress echocardiography. Experience in 1118 patients. Circulation 88(1):15–19PubMedCrossRefGoogle Scholar
  17. 17.
    Nagel E, et al (1999) Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation 99(6):763–770PubMedCrossRefGoogle Scholar
  18. 18.
    Nagel E, et al (1999) [Influence of image quality on the diagnostic accuracy of dobutamine stress magnetic resonance imaging in comparison with dobutamine stress echocardiography for the noninvasive detection of myocardial ischemia]. Z Kardiol 88(9):622–630PubMedCrossRefGoogle Scholar
  19. 19.
    Nagel E, et al (2000) Magnetic resonance realtime imaging for the evaluation of left ventricular function. J Cardiovasc Magn Reson 2(1):7–14CrossRefGoogle Scholar
  20. 20.
    Nagel E, et al (2001) Stress cardiovascular magnetic resonance: consensus panel report. J Cardiovasc Magn Reson 3(3):267–281PubMedCrossRefGoogle Scholar
  21. 21.
    Pennell DJ, et al (1992) Magnetic resonance imaging during dobutamine stress in coronary artery disease. Am J Cardiol 70(1):34–40PubMedCrossRefGoogle Scholar
  22. 22.
    Picano E (1997) Symptoms and signs of myocardial ischemia. Berlin; Heidelberg, New York: Springer Verlag, pp 19–24Google Scholar
  23. 23.
    Picano E, et al (1994) Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, multicentre study. Echo Dobutamine International Cooperative Study Group. Lancet 344(8931):1190–1192PubMedCrossRefGoogle Scholar
  24. 24.
    Plein S, et al (2002) Coronary artery disease: assessment with a comprehensive MR imaging protocol-initial results. Radiology 225(1):300–307PubMedCrossRefGoogle Scholar
  25. 25.
    Pohost G, et al (2000) Guidelines for credentialing in cardiovascular magnetic resonance (CMR). J Cardiovasc Magn Reson 2:233–234CrossRefGoogle Scholar
  26. 26.
    Power T., et al (1997) Breath-hold dobutamine magnetic resonance myocardial tagging: normal left ventricular response. Am J Cardiol 80:1203–1207PubMedCrossRefGoogle Scholar
  27. 27.
    Rina IL, et al (1995) Guidelines for clinical exercise testing laboratories. Circulation 91:912CrossRefGoogle Scholar
  28. 28.
    Sandstede J., et al (1999) Detection of myocardial viability by low-do se dobutamine Cine MR imaging. Magn Reson Imaging 17(10): 1437–1443PubMedCrossRefGoogle Scholar
  29. 29.
    Schalla, S., et al (2002) Real-time MR image acquisition during high-dose dobutamine hydrochloride stress for detecting left ventricular wall-motion abnormalities in patients with coronary arterial disease. Radiology 224(3):845–851PubMedCrossRefGoogle Scholar
  30. 30.
    Scheidegger MB, et al (1998) Assessment of cardiac wall thickening and ejection fraction from real time cardiac MR images in patients with left ventricular dysfunction. In: Proceedings of the International Society of Magnetic Resonance in Medicine. SydneyGoogle Scholar
  31. 31.
    Sensky PR, et al (2000) Coronary artery disease: combined stress MR imaging protocol-one-stop evaluation of myocardial perfusion and function. Radiology 215(2):608–614PubMedGoogle Scholar
  32. 32.
    van Rugge FP, et al (1993) Dobutamine stress magnetic resonance imaging for detection of coronary artery disease. J Am Coll Cardiol 22(2):431–439PubMedCrossRefGoogle Scholar
  33. 33.
    Wahl A, Paetsch I, Gollesch A, Roethemeyer S, Gebker R, Foell D, Fleck E, Nagel E (2003) Safety and feasibility of high-dose dobutamineatropine stress cardiovascular magnetic resonance for diagnosis of myocardial ischemia: Experience in 1000 consecutive cases. Eur Heart J 24 (suppl):443CrossRefGoogle Scholar
  34. 34.
    Wahl A, et al (2002) Simultaneous assessment of wall motion and myocardial perfusion during high dose dobutamine stress MRI improves diagnoses of ischemia in patients with known coronary artery disease. J Cardiovasc Magn Reson, pp 136–137 (abstract)Google Scholar
  35. 35.
    Yang PC, et al (1998) New real-time interactive cardiac magnetic resonance imaging system complements echocardiography. J Am Coll Cardiol 32:2049–2056PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2004

Authors and Affiliations

  • Eike Nagel

There are no affiliations available

Personalised recommendations